
Abiomed ABMD
Quarterly report 2023-Q2
added 05-23-2026
Abiomed Interest Expense 2011-2026 | ABMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Abiomed
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.8 M | 58.7 M | 7.61 M | 30.4 M | -388 K | -349 K | 339 K | -97 K | 49 K | 326 K | 9 K | -143 K | -39 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.7 M | -388 K | 11.2 M |
Quarterly Interest Expense Abiomed
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80.7 M | 3.77 M | - | -7.58 M | 5.86 M | 38.9 M | -7.58 M | 7.94 M | 9.76 M | 24.6 M | 7.94 M | 23.7 M | -45.8 M | 39.4 M | 23.7 M | -20 K | -158 K | 188 K | -20 K | -81 K | -23 K | 79 K | -81 K | -34 K | -114 K | -77 K | -34 K | -29 K | 87 K | - | -29 K | 111 K | 140 K | 53 K | -10 K | -10 K | -39 K | 11 K | 20 K | 20 K | 6 K | -21 K | 324 K | 324 K | -9 K | -4 K | 39 K | 39 K | 66 K | -81 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 80.7 M | -45.8 M | 4.29 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.35 | 1.16 % | $ 163 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.65 | 1.79 % | $ 330 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 8.04 | -2.84 % | $ 1.21 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.29 | - | $ 50.5 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.95 | -2.38 % | $ 71.2 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.54 | -0.65 % | $ 62.7 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.91 | -2.5 % | $ 420 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.83 | -1.77 % | $ 388 M | ||
|
Myomo
MYO
|
-668 K | $ 1.02 | -0.97 % | $ 42.7 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 75.68 | 2.51 % | $ 4.13 B | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 9.57 | -10.98 % | $ 379 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.67 | 1.24 % | $ 542 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.89 | 0.88 % | $ 208 M | ||
|
Electromed
ELMD
|
455 K | $ 38.09 | -0.34 % | $ 322 M | ||
|
Butterfly Network
BFLY
|
2.77 M | $ 4.57 | 2.13 % | $ 1.13 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.43 | 1.67 % | $ 6.74 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 85.48 | 0.79 % | $ 11.6 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 153.42 | -0.94 % | $ 10.8 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.13 | -3.02 % | $ 1.12 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 42.27 | -3.58 % | $ 1.24 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 91.06 | 1.99 % | $ 3.16 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 87.65 | 2.18 % | $ 51.3 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 70.26 | 1.91 % | $ 2.39 B |